Study of PARPi 2X-121 as Monotherapy and in Combination With Dovitinib in Patients With Advanced Solid Tumors
Clinical trial NCT05571969 · TERMINATED
Trial details
- NCT number
- NCT05571969
- Sponsor
- Allarity Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-02-19
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.